img

Global Drug of Abuse Screening Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug of Abuse Screening Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Drug of Abuse Screening report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Drug of Abuse Screening market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Medical and Research are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug of Abuse Screening market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories, Inc.
Thermo Fisher Scientific
LabCorp (Laboratory Corporation of America)
Psychemedics Corporation
Sonic Healthcare
Bio-Rad Laboratories
Quest Diagnostics
Randox Laboratories
F. Hoffman-La Roche
Segment by Type
On-Site Screening
Laboratory-Based Screening

Segment by Application


Medical
Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug of Abuse Screening market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug of Abuse Screening introduction, etc. Drug of Abuse Screening Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug of Abuse Screening market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Drug of Abuse Screening
1.1 Drug of Abuse Screening Market Overview
1.1.1 Drug of Abuse Screening Product Scope
1.1.2 Drug of Abuse Screening Market Status and Outlook
1.2 Global Drug of Abuse Screening Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Drug of Abuse Screening Market Size by Region (2018-2033)
1.4 Global Drug of Abuse Screening Historic Market Size by Region (2018-2023)
1.5 Global Drug of Abuse Screening Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Drug of Abuse Screening Market Size (2018-2033)
1.6.1 North America Drug of Abuse Screening Market Size (2018-2033)
1.6.2 Europe Drug of Abuse Screening Market Size (2018-2033)
1.6.3 Asia-Pacific Drug of Abuse Screening Market Size (2018-2033)
1.6.4 Latin America Drug of Abuse Screening Market Size (2018-2033)
1.6.5 Middle East & Africa Drug of Abuse Screening Market Size (2018-2033)
2 Drug of Abuse Screening Market by Type
2.1 Introduction
2.1.1 On-Site Screening
2.1.2 Laboratory-Based Screening
2.2 Global Drug of Abuse Screening Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Drug of Abuse Screening Historic Market Size by Type (2018-2023)
2.2.2 Global Drug of Abuse Screening Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug of Abuse Screening Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Drug of Abuse Screening Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Drug of Abuse Screening Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Drug of Abuse Screening Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Drug of Abuse Screening Revenue Breakdown by Type (2018-2033)
3 Drug of Abuse Screening Market Overview by Application
3.1 Introduction
3.1.1 Medical
3.1.2 Research
3.2 Global Drug of Abuse Screening Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Drug of Abuse Screening Historic Market Size by Application (2018-2023)
3.2.2 Global Drug of Abuse Screening Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug of Abuse Screening Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Drug of Abuse Screening Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Drug of Abuse Screening Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Drug of Abuse Screening Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Drug of Abuse Screening Revenue Breakdown by Application (2018-2033)
4 Drug of Abuse Screening Competition Analysis by Players
4.1 Global Drug of Abuse Screening Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2022)
4.3 Date of Key Players Enter into Drug of Abuse Screening Market
4.4 Global Top Players Drug of Abuse Screening Headquarters and Area Served
4.5 Key Players Drug of Abuse Screening Product Solution and Service
4.6 Competitive Status
4.6.1 Drug of Abuse Screening Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories, Inc.
5.1.1 Abbott Laboratories, Inc. Profile
5.1.2 Abbott Laboratories, Inc. Main Business
5.1.3 Abbott Laboratories, Inc. Drug of Abuse Screening Products, Services and Solutions
5.1.4 Abbott Laboratories, Inc. Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories, Inc. Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Drug of Abuse Screening Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 LabCorp (Laboratory Corporation of America)
5.3.1 LabCorp (Laboratory Corporation of America) Profile
5.3.2 LabCorp (Laboratory Corporation of America) Main Business
5.3.3 LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Products, Services and Solutions
5.3.4 LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.3.5 Psychemedics Corporation Recent Developments
5.4 Psychemedics Corporation
5.4.1 Psychemedics Corporation Profile
5.4.2 Psychemedics Corporation Main Business
5.4.3 Psychemedics Corporation Drug of Abuse Screening Products, Services and Solutions
5.4.4 Psychemedics Corporation Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.4.5 Psychemedics Corporation Recent Developments
5.5 Sonic Healthcare
5.5.1 Sonic Healthcare Profile
5.5.2 Sonic Healthcare Main Business
5.5.3 Sonic Healthcare Drug of Abuse Screening Products, Services and Solutions
5.5.4 Sonic Healthcare Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.5.5 Sonic Healthcare Recent Developments
5.6 Bio-Rad Laboratories
5.6.1 Bio-Rad Laboratories Profile
5.6.2 Bio-Rad Laboratories Main Business
5.6.3 Bio-Rad Laboratories Drug of Abuse Screening Products, Services and Solutions
5.6.4 Bio-Rad Laboratories Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.6.5 Bio-Rad Laboratories Recent Developments
5.7 Quest Diagnostics
5.7.1 Quest Diagnostics Profile
5.7.2 Quest Diagnostics Main Business
5.7.3 Quest Diagnostics Drug of Abuse Screening Products, Services and Solutions
5.7.4 Quest Diagnostics Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.7.5 Quest Diagnostics Recent Developments
5.8 Randox Laboratories
5.8.1 Randox Laboratories Profile
5.8.2 Randox Laboratories Main Business
5.8.3 Randox Laboratories Drug of Abuse Screening Products, Services and Solutions
5.8.4 Randox Laboratories Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.8.5 Randox Laboratories Recent Developments
5.9 F. Hoffman-La Roche
5.9.1 F. Hoffman-La Roche Profile
5.9.2 F. Hoffman-La Roche Main Business
5.9.3 F. Hoffman-La Roche Drug of Abuse Screening Products, Services and Solutions
5.9.4 F. Hoffman-La Roche Drug of Abuse Screening Revenue (US$ Million) & (2018-2023)
5.9.5 F. Hoffman-La Roche Recent Developments
6 North America
6.1 North America Drug of Abuse Screening Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Drug of Abuse Screening Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse Screening Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug of Abuse Screening Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse Screening Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug of Abuse Screening Market Dynamics
11.1 Drug of Abuse Screening Industry Trends
11.2 Drug of Abuse Screening Market Drivers
11.3 Drug of Abuse Screening Market Challenges
11.4 Drug of Abuse Screening Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Drug of Abuse Screening Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Drug of Abuse Screening Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Drug of Abuse Screening Market Size Share by Region (2018-2023)
Table 4. Global Drug of Abuse Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Drug of Abuse Screening Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Drug of Abuse Screening Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Drug of Abuse Screening Revenue Market Share by Type (2018-2023)
Table 9. Global Drug of Abuse Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Drug of Abuse Screening Revenue Market Share by Type (2024-2033)
Table 11. North America Drug of Abuse Screening Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Drug of Abuse Screening Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Drug of Abuse Screening Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Drug of Abuse Screening Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Drug of Abuse Screening Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Drug of Abuse Screening Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Drug of Abuse Screening Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Drug of Abuse Screening Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Drug of Abuse Screening Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Drug of Abuse Screening Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Drug of Abuse Screening Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Drug of Abuse Screening Revenue Market Share by Application (2018-2023)
Table 24. Global Drug of Abuse Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Drug of Abuse Screening Revenue Market Share by Application (2024-2033)
Table 26. North America Drug of Abuse Screening Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Drug of Abuse Screening Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Drug of Abuse Screening Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Drug of Abuse Screening Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Drug of Abuse Screening Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Drug of Abuse Screening Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Drug of Abuse Screening Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Drug of Abuse Screening Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Drug of Abuse Screening Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Drug of Abuse Screening Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Drug of Abuse Screening Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Drug of Abuse Screening Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2022)
Table 39. Date of Key Players Enter into Drug of Abuse Screening Market
Table 40. Global Drug of Abuse Screening Key Players Headquarters and Area Served
Table 41. Drug of Abuse Screening Product Solution and Service
Table 42. Global Drug of Abuse Screening Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Laboratories, Inc. Basic Information List
Table 45. Abbott Laboratories, Inc. Description and Business Overview
Table 46. Abbott Laboratories, Inc. Drug of Abuse Screening Products, Services and Solutions
Table 47. Revenue (US$ Million) in Drug of Abuse Screening Business of Abbott Laboratories, Inc. (2018-2023)
Table 48. Abbott Laboratories, Inc. Recent Developments
Table 49. Thermo Fisher Scientific Basic Information List
Table 50. Thermo Fisher Scientific Description and Business Overview
Table 51. Thermo Fisher Scientific Drug of Abuse Screening Products, Services and Solutions
Table 52. Revenue (US$ Million) in Drug of Abuse Screening Business of Thermo Fisher Scientific (2018-2023)
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. LabCorp (Laboratory Corporation of America) Basic Information List
Table 55. LabCorp (Laboratory Corporation of America) Description and Business Overview
Table 56. LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Products, Services and Solutions
Table 57. Revenue (US$ Million) in Drug of Abuse Screening Business of LabCorp (Laboratory Corporation of America) (2018-2023)
Table 58. LabCorp (Laboratory Corporation of America) Recent Developments
Table 59. Psychemedics Corporation Basic Information List
Table 60. Psychemedics Corporation Description and Business Overview
Table 61. Psychemedics Corporation Drug of Abuse Screening Products, Services and Solutions
Table 62. Revenue (US$ Million) in Drug of Abuse Screening Business of Psychemedics Corporation (2018-2023)
Table 63. Psychemedics Corporation Recent Developments
Table 64. Sonic Healthcare Basic Information List
Table 65. Sonic Healthcare Description and Business Overview
Table 66. Sonic Healthcare Drug of Abuse Screening Products, Services and Solutions
Table 67. Revenue (US$ Million) in Drug of Abuse Screening Business of Sonic Healthcare (2018-2023)
Table 68. Sonic Healthcare Recent Developments
Table 69. Bio-Rad Laboratories Basic Information List
Table 70. Bio-Rad Laboratories Description and Business Overview
Table 71. Bio-Rad Laboratories Drug of Abuse Screening Products, Services and Solutions
Table 72. Revenue (US$ Million) in Drug of Abuse Screening Business of Bio-Rad Laboratories (2018-2023)
Table 73. Bio-Rad Laboratories Recent Developments
Table 74. Quest Diagnostics Basic Information List
Table 75. Quest Diagnostics Description and Business Overview
Table 76. Quest Diagnostics Drug of Abuse Screening Products, Services and Solutions
Table 77. Revenue (US$ Million) in Drug of Abuse Screening Business of Quest Diagnostics (2018-2023)
Table 78. Quest Diagnostics Recent Developments
Table 79. Randox Laboratories Basic Information List
Table 80. Randox Laboratories Description and Business Overview
Table 81. Randox Laboratories Drug of Abuse Screening Products, Services and Solutions
Table 82. Revenue (US$ Million) in Drug of Abuse Screening Business of Randox Laboratories (2018-2023)
Table 83. Randox Laboratories Recent Developments
Table 84. F. Hoffman-La Roche Basic Information List
Table 85. F. Hoffman-La Roche Description and Business Overview
Table 86. F. Hoffman-La Roche Drug of Abuse Screening Products, Services and Solutions
Table 87. Revenue (US$ Million) in Drug of Abuse Screening Business of F. Hoffman-La Roche (2018-2023)
Table 88. F. Hoffman-La Roche Recent Developments
Table 89. North America Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 90. North America Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 91. Europe Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 92. Europe Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 93. Asia-Pacific Drug of Abuse Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 94. Asia-Pacific Drug of Abuse Screening Market Size by Region (2018-2023) & (US$ Million)
Table 95. Asia-Pacific Drug of Abuse Screening Market Size by Region (2024-2033) & (US$ Million)
Table 96. Asia-Pacific Drug of Abuse Screening Market Share by Region (2018-2023)
Table 97. Asia-Pacific Drug of Abuse Screening Market Share by Region (2024-2033)
Table 98. Latin America Drug of Abuse Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 99. Latin America Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 100. Latin America Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 101. Middle East & Africa Drug of Abuse Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 102. Middle East & Africa Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 103. Middle East & Africa Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 104. Drug of Abuse Screening Market Trends
Table 105. Drug of Abuse Screening Market Drivers
Table 106. Drug of Abuse Screening Market Challenges
Table 107. Drug of Abuse Screening Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse Screening Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Drug of Abuse Screening Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Drug of Abuse Screening Market Share by Regions: 2022 VS 2033
Figure 4. Global Drug of Abuse Screening Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Drug of Abuse Screening Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Drug of Abuse Screening Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Drug of Abuse Screening Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Drug of Abuse Screening Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Drug of Abuse Screening Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of On-Site Screening
Figure 11. Global On-Site Screening Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Laboratory-Based Screening
Figure 13. Global Laboratory-Based Screening Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Global Drug of Abuse Screening Market Size Share by Type: 2022 & 2033
Figure 15. North America Drug of Abuse Screening Revenue Market Share by Type (2018-2033)
Figure 16. Europe Drug of Abuse Screening Revenue Market Share by Type (2018-2033)
Figure 17. Asia-Pacific Drug of Abuse Screening Revenue Market Share by Type (2018-2033)
Figure 18. Latin America Drug of Abuse Screening Revenue Market Share by Type (2018-2033)
Figure 19. Middle East and Africa Drug of Abuse Screening Revenue Market Share by Type (2018-2033)
Figure 20. Medical Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 21. Research Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 22. Global Drug of Abuse Screening Market Size Share by Application: 2022 & 2033
Figure 23. North America Drug of Abuse Screening Revenue Market Share by Application (2018-2033)
Figure 24. Europe Drug of Abuse Screening Revenue Market Share by Application (2018-2033)
Figure 25. Asia-Pacific Drug of Abuse Screening Revenue Market Share by Application (2018-2033)
Figure 26. Latin America Drug of Abuse Screening Revenue Market Share by Application (2018-2033)
Figure 27. Middle East and Africa Drug of Abuse Screening Revenue Market Share by Application (2018-2033)
Figure 28. Drug of Abuse Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Drug of Abuse Screening Market Share in 2022
Figure 30. North America Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 31. United States Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 32. Canada Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 33. Germany Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 34. France Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 35. U.K. Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 36. Italy Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 37. Russia Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 38. Nordic Countries Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Drug of Abuse Screening Market Share by Region (2018-2033)
Figure 40. China Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 41. Japan Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 42. South Korea Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 44. India Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 45. Australia Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 46. Latin America Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 47. Mexico Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 48. Brazil Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 49. Middle East & Africa Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 50. Turkey Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 51. Saudi Arabia Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 52. UAE Drug of Abuse Screening Market Size (2018-2033) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report